Phase 1/2 Trial of Oral EPI-7386 (masofaniten) in Combination with Enzalutamide (enz) Compared to Enz Alone in Patients with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Phase 1 (P1) Results and Phase 2 (P2) Design.

Christos Kyriakopoulos,Gurkamal S. Chatta,Andrew Leonard Laccetti,Nicholas Iannotti,Alexandra Sokolova,Sebastien J. Hotte,Ronald F. Tutrone,Mark Christopher Markowski,Luke T. Nordquist,Roberto Pili,Fred Saad,Jingsong Zhang,Karen Villaluna, Brett Younginger,Ronan Le Moigne,Alessandra Cesano

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views7
No score
Key words
283-2494-5577-2829-12292,613-225-2782,261-492-2769,261-566-9263,613-225-325,261-492-3532-9726,60,60,13
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined